Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment
FCGR2B表达对弥漫性大B细胞淋巴瘤患者利妥昔单抗或奥妥珠单抗治疗反应的预后意义
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2021004770
Nowicka, Malgorzata; Hilton, Laura K; Ashton-Key, Margaret; Hargreaves, Chantal E; Lee, Chern; Foxall, Russell; Carter, Matthew J; Beers, Stephen A; Potter, Kathleen N; Bolen, Christopher R; Klein, Christian; Knapp, Andrea; Mir, Farheen; Rose-Zerilli, Matthew; Burton, Cathy; Klapper, Wolfram; Scott, David W; Sehn, Laurie H; Vitolo, Umberto; Martelli, Maurizio; Trneny, Marek; Rushton, Christopher K; Slack, Graham W; Farinha, Pedro; Strefford, Jonathan C; Oestergaard, Mikkel Z; Morin, Ryan D; Cragg, Mark S